If you’ve been following the news, you may have noticed that cannabidiol (CBD) is becoming a modern-day panacea. Hundreds of thousands of people are using CBD to regulate their stress and moods, to treat insomnia, to fight runaway inflammation and more — all without the “high” that can make regular treatment with cannabis impractical.

Cannabis users are no strangers to being judged based on unproven stereotypes. For decades we were told that marijuana use would kill our brain cells, fill our lungs with cancer and lead us down a road to harder drugs and eventually an early death. And while the Internet has done much to dispel those myths, the spread of information works both ways.

The ever-increasing cannabinoid family has new members coming in every day, and there’s reason to be excited as new research comes out about CBC.

In the last couple of years, CBD (cannabidiol) – a cannabis cannabinoid, has risen to prominence as an effective treatment for many suffering from medical issues like insomnia, anxiety, pain, depression, seizures, high blood sugars, pathogenic diseases, ADHD etc., and a possible answer to many other issues that still require more research like: different forms of cancer, neurodegenerative diseases, and even prion diseases. It seems like every day a new breakthrough is coming out about the use of CBD as a treatment.

A bunch of celebrities have been jumping on the medical and adult-use cannabis bandwagon. Where they haven’t; some have been pushed onto it – without permission.

The last thing a relatively new industry needs are snake-oil salesmen and shonky marketing tactics, particularly where that industry is focused on health and wellness.

Five years ago the shelves of most dispensaries housed sugary edibles, strong concentrates and a selection of flower with as much THC as a grower could manage. The industry and its products were geared towards the male consumer who dominated the market.

Fast forward to 2020 and markets like California are seeing a rise of women-centric cannabis products and services -- low dose mints, high end topical oils and lotions, CBD bath balms, mini-joints with low levels of THC that everyone can enjoy.

You might have thought that 2019 would be a great year for cannabidiol (CBD) stocks. I certainly did. After all, hemp-derived CBD was legalized in the U.S. in December 2018, when the 2018 Farm Bill passed both houses of Congress and was signed into law by the president.

But an ominous consumer warning by the Food and Drug Administration (FDA) in November caused marijuana stocks, especially those with CBD business in the U.S., to collapse. Now, though, there's a good reason to think that CBD stocks could soon skyrocket and not look back. Here's why.

Some medical experts believe CBD can help manage the symptoms of the common cold and flu.

As we enter into winter cold and flu season, it’s time to stock up on remedies to help when you’re under the weather. With all the buzz around cannabidiol (CBD), should you consider adding CBD as part of your home remedy cold/flu kit to help relieve symptoms such as a sore throat, stuffy nose, and body pain?

Research suggests CBD could help manage varicose veins via influence on the cardiovascular system.

Varicose or spider veins can be as upsetting as they are signaling to a larger issue in the body. The Chicago Vein Institute estimates that over 40 million people in the United States suffer from varicose veins.

Marijuana proponents are ecstatic because this super THC discovery means there is higher quality medicine from this plant.

From a group of European researchers comes news of the discovery of a super-cannabis compound, a cannabinoid 30 times stronger than THC. It was discovered while they were looking for additional medicinal qualities in a host of cannabinoids among 150 known to exist.

It’s called THCP, and researchers were stunned: “The presence of this new phytocannabinoid could account for the pharmacological properties of some cannabis varieties difficult to explain by the presence of the sole Delta-9-THC.”